Along with the frequent outbreaks of animal epidemics, the government's
increasing investment in epidemic prevention and the implementation of
compulsory immunization system, Chinese animal vaccine market shows vigorous
development. In 2011, the market size of animal vaccine in China hit RMB7.92
billion. Since 2004, foot-and-mouth disease, highly pathogenic avian influenza
(HPAI), highly pathogenic porcine reproductive and respiratory syndrome
(HP-PRRS), swine fever and peste des petits ruminants have been brought into
the scope of compulsory immunization by the government, which promotes the
animal vaccine market to grow 28.1% annually. It is expected that Chinese
market size of animal vaccine will amount to RMB9.56 billion in 2012.
Market Size of Chinese Animal Vaccine, 2000-2011
Source: Ministry of Agrivculture of P.R.C.; China Veterinary Drug
Association;ResearchiChina(China Animal Vaccine Industry Report, 2011-2012)
Pig and poultry raising is the backbone of Chinese animal husbandry, and the
swine and poultry vaccines occupy more than 80% of China's animal vaccine
market. In 2011, the total sales of animal vaccines produced by Chinese animal
vaccine enterprises approximated RMB7.11 billion (excluding net import value),
of which the sales of swine vaccine and poultry vaccine registered RMB3.51
billion and RMB3.01 billion respectively, making up 49.4% and 42.3% of the
total sales separately.
Chinese animal vaccine industry features high degree of industry
concentration. In 2011, among major Chinese animal vaccine manufacturers,
China Animal Husbandry Industry Co., Ltd. ranked No. 1 for its revenue of
RMB1.18 billion, accounting for 14.9% market share. Moreover, the companies
with market share of over 5.0% also include Xinjiang Tecon Animal Husbandry
Bio-technology Co., Ltd., Guangdong Dahuanong Animal Health Products Co., Ltd.
and Jinyu Group. As the state strengthens the regulatory oversight and the
consumer's brand awareness is improving, the concentration degree of Chinese
animal vaccine industry will be enhanced as well.
It is in the report that covers the followings:
The market size, market structure, competitive landscape and technology
development direction of the global animal vaccine industry;
The market size, import & export, profit, entry barriers, competition
pattern and entry of foreign capital of Chinese animal vaccine industry;
Policy environment, compulsory immunization tendering system, reform
direction and its influence on downstream husbandry development;
The forecasts of Chinese animal vaccine industry, including overall
market, swine vaccine, poultry vaccine, cattle & sheep vaccine and pet
vaccine, etc.;
Production, operation, investment, M&A, clients and suppliers, animal
vaccine business and development forecast of 11 major animal vaccine
enterprises in China.
STUDY GOAL AND OBJECTIVES
This report provides the industry executives with strategically
significantcompetitor information, analysis, insight and projection on
thecompetitive pattern and key companies in the industry, crucial to
thedevelopment and implementation of effective business, marketing andR&D
programs.
REPORT OBJECTIVES
To establish a comprehensive, factual, annually updated and cost-effective
information base on market size, competition patterns, market segments, goals
and strategies of the leading players in the market, reviews and forecasts.
To assist potential market entrants in evaluating prospective acquisition
and joint venture candidates.
To complement the organizations' internal competitor information gathering
efforts with strategic analysis, data interpretation and insight.
To suggest for concerned investors in line with the current development of
this industry as well as the development tendency.
To help company to succeed in a competitive market, and
METHODOLOGY
Both primary and secondary research methodologies were used in preparing this
study. Initially, a comprehensive and exhaustive search of the literature on
this industry was conducted. These sources included related books and
journals, trade literature, marketing literature, other product/promotional
literature, annual reports, security analyst reports, and other publications.
Subsequently, telephone interviews or email correspondence was conducted with
marketing executives etc. Other sources included related magazines, academics,
and consulting companies.
INFORMATION SOURCES
The primary information sources include NBS (National Bureau of Statistics of
China), China Customs and annual reports of listed companies etc.
About ResearchInChina
ResearchInChina was established in 1999, has become a leading
independent provider of China business intelligence. Our research is designed
to meet the diverse planning and information needs of businesses,
institutions, and professional investors worldwide. Our services are used in a
variety of ways, including strategic planning, product and sales forecasting,
risk and sensitivity management, and as investment research.
Table of Contents
Table of Contents
1. Overview of Animal Vaccine
1.1. Definition
1.2. Classification
1.3. Industry Chain
2. Status Quo of Animal Vaccine Industry
2.1. Global Market
2.1.1. Market Size
2.1.2. Market Structure
2.1.3. Competitive Landscape
2.1.4. New Epidemics and Products
2.2. Chinese Market
2.2.1. Market Size
2.2.2. Import and Export
2.2.3. Profit
2.2.4. Entry Barriers
2.2.5. Competitive Landscape
3. Development Environment of Animal Vaccine Industry in China
3.1. Policy Environment
3.1.1. Major Policies
3.1.2. Tendering System for Compulsory Immunization Vaccine
3.2. Social Environment
3.2.1. Rapid Development of Husbandry
3.2.2. Large-scale Husbandry Becomes a Trend
3.2.3. Frequent Outbreaks of Animal Epidemics
4. Development Forecast of Animal Vaccine Industry in China
4.1. Overall Forecast
4.2. Swine Vaccines
4.3. Poultry Vaccines
4.4. Cattle & Sheep Vaccines
4.5. Pet Vaccines
5. Key Enterprises
5.1. CAHIC
5.1.1. Profile
5.1.2. Operation
5.1.3. Revenue Structure
5.1.4. Gross Margin
5.1.5. Clients and Suppliers
5.1.6. Animal Vaccine Business
5.1.7. Forecast and Outlook
5.2. Jinyu Group
5.2.1. Profile
5.2.2. Operation
5.2.3. Revenue Structure
5.2.4. Gross Margin
5.2.5. R&D and Investment
5.2.6. Clients
5.2.7. Animal Vaccine Business
5.2.8. Forecast and Outlook
5.3. Tecon
5.3.1. Profile
5.3.2. Operation
5.3.3. Revenue Structure
5.3.4. Gross Margin
5.3.5. R& D and Investment
5.3.6. Clients and Suppliers
5.3.7. Animal Vaccine Business
5.3.8. Forecast and Outlook
5.4. Tech-bank
5.4.1. Profile
5.4.2. Operation
5.4.3. Revenue Structure
5.4.4. Gross Margin
5.4.5. R&D and Investment
5.4.6. Clients and Suppliers
5.4.7. Animal Vaccine Business
5.4.8. Forecast and Outlook
5.5. Shenghua Biok
5.5.1. Profile
5.5.2. Operation
5.5.3. Revenue Structure
5.5.4. Gross Margin
5.5.5. Clients and Suppliers
5.5.6. Animal Vaccine Business
5.5.7. Forecast and Outlook
5.6. Huasun Group
5.6.1. Profile
5.6.2. Operation
5.6.3. Revenue Structure
5.6.4. Gross Margin
5.6.5. Clients and Suppliers
5.6.6. Animal Vaccine Business
5.6.7. Forecast and Outlook
5.7. Harbin Pharmaceutical Group
5.7.1. Profile
5.7.2. Animal Vaccine Business
5.8. Ringpu Bio-technology
5.8.1. Profile
5.8.2. Operation
5.8.3. Revenue Structure
5.8.4. Gross Margin
5.8.5. R&D and Investment
5.8.6. Clients and Suppliers
5.8.7. Animal Vaccine Business
5.8.8. Forecast and Outlook
5.9. Dahuanong
5.9.1. Profile
5.9.2. Operation
5.9.3. Revenue Structure
5.9.4. Gross Margin
5.9.5. R&D and Investment
5.9.6. Clients and Suppliers
5.9.7. Animal Vaccine Business
5.9.8. Forecast and Outlook
5.10. Yikang
5.10.1. Profile
5.10.2. Operation
5.10.3. Revenue Structure
5.10.4. Gross Margin
5.10.5. R&D and Investment
5.10.6. Clients and Suppliers
5.10.7. Animal Vaccine Business
5.11. Chopper
5.11.1. Profile
5.11.2. Operation
5.11.3. Revenue Structure
5.11.4. Gross Margin
5.11.5. R&D and Investment
5.11.6. Clients and Suppliers
5.11.7. Animal Vaccine Business
Selected Charts
Classification of Animal Health Products
Animal Vaccine Types (by Constituent and Feature) and Characteristics
Animal Vaccine Industry Chain
Classification of Animal Epidemics in China
Sales of Global Animal Vaccine, 2008-2014E
Profile of Global Animal Health Products Giants
Revenue of Animal Vaccine Business of Global Major Animal Health Products
Enterprises, 2010
Revenue Structure of Global Major Animal Health Products Enterprises (by
Product), 2010
Commercialized Vaccines and Manufacturers in Overseas Market in Recent
Years
Market Size of Chinese Animal Vaccine, 2000-2011
Market Structure of Chinese Animal Vaccine (by Animal Species), 2008-2011
Export Volume and Export Value of Chinese Animal Vaccine, 2007-2011
Oversea Market Distribution of Chinese Animal Vaccine, 2011
Average Export Prices of China's Animal Vaccine, 2007-2011
Import Volume and Import Value of Chinese Animal Vaccine, 2007-2011
Origins of China's Imported Animal Vaccines, 2011
Average Import Prices of Animal Vaccine in China, 2007-2011
Gross Margin of Animal Vaccine Enterprises of Different Scale in China,
2010
Gross Margin of Animal Vaccine Business of Major Listed Animal Vaccine
Companies in China, 2011
Barriers to Entry into Animal Vaccine Industry in China
Revenue of Animal Vaccine Enterprises (by Company Type) in China, 2010
Revenue of Animal Vaccine Business of Major Listed Animal Vaccine
Companies in China, 2011
Production of China's Key Animal Vaccine Manufacturers
Industry Concentration of Animal Vaccine Industry(by Animal Species) in
China, 2011
Gap between Chinese Vaccine Production Process and International Advanced
Level
Major Polices on Animal Vaccine Industry in China, 2010-Apr. 2012
Compulsory Immunization Plan of Animal Epidemics in China, 2011
Prices of Governmental Tender Vaccine, 2009 and 2011
Defect of Compulsory Vaccination Tender System in China
Reform Direction of Compulsory Vaccination Tender System in China
Output of Meat, Eggs and Milk in China, 2007-2011
Per-capita Consumption of Meat in China, 1990-2020E
Meat Consumption Structure of Urban Residents in China, 1990-2010
Meat Consumption Structure of Rural Residents in China, 1990-2010
Meat Consumption Structure of Chinese Residents, 2020E
Market Capacity of Meat in China, 2020E
Proportion of Epidemic Prevention Expense in the Cost of Pig Breeding in
China, 2005-2010
Breeding Scale Degree in China, 2010-2020E
Epidemic Prevention Costs of Pig Breeding in China, 2005-2010
Epidemic Prevention Cost per One Hundred Broilers and Layers in China, 2010
Overview of Common Animal Epidemic Situation in China
Major Animal Epidemics Reported by China to OIE, 2007-2012
Market Size of Chinese Animal Vaccine, 2007-2012
Market Structure of Chinese Animal Vaccine (by Animal Species), 2010-2012
Pig Breeding Stock and Slaughter Quantity in China, 2000-2011
Sales of Swine Vaccine of Animal Vaccine Enterprises in China, 2008-2012
Market Competition of PCV Vaccine in China, 2011
Sales of Poultry Vaccine of Animal Vaccine Enterprises in China, 2008-2012
Sales of Cattle & Sheep Vaccine of Animal Vaccine Enterprises in China,
2008-2012
Provincial Per Capita GDP in China, 2011
Birth Rate in China, 1952-2011
Sales of Pet Vaccine Enterprises in China, 2008-2012
Pet Vaccine Suppliers in Chinese Market
Revenue and Net Income of CAHIC, 2008-2011
Revenue of CAHIC by Product, 2008-2011
Revenue of CAHIC by Region, 2008-2011
Gross Margin of Main Products of CAHIC, 2008-2011
CAHIC's Sales from Top 5 Clients and % of Total Revenue, 2008-2011
CAHIC's Procurement from Top 5 Suppliers and % of Total Procurement,
2008-2011
Sales Volume of CAHIC Animal Vaccines, 2007-2011
Animal Vaccine Capacity Distribution of CAHIC
Revenue and Net Income of CAHIC, 2011-2013E
Revenue and Net Income of Jinyu Group, 2008-2011
Revenue of Jinyu Group by Product, 2008-2011
Revenue of Jinyu Group by Region, 2008-2011
Gross Margin of Main Products of Jinyu Group, 2008-2011
R&D Costs and % of Total Revenue of Jinyu Group, 2009-2011
Jinyu Group's Sales from Top 5 Clients and % of Total Revenue, 2008-2011
Animal Vaccine Capacity Distribution of Jinyu Group
Revenue and Gross Margin of Biological Products Business of Jinyu Group,
2008-2011
Revenue and Net Income of Jinyu Group, 2011-2013E
Revenue and Net Income of Tecon, 2008-2011
Revenue of Tecon by Product, 2008-2011
Revenue of Tecon by Region, 2008-2011
Gross Margin of Main Products of Tecon, 2008-2011
R&D Costs and % of Total Revenue of Tecon, 2008-2011
Tecon's Sales from Top 5 Clients and % of Total Revenue, 2008-2011
Name list and Revenue Contribution of Tecon's Top 5 Clients, 2011
Name list, procurement and % of Tecon's Top 5 Suppliers, 2011
Revenue and Gross Margin of Tecon's Animal Vaccine Business, 2007-2011
Animal Vaccine R & D Projects and Progress of Tecon, by the End of 2011
Animal Vaccine Investment Projects of Tecon, 2011
Revenue and Net Income of Tecon, 2011-2013E
Revenue and Net Income of Tech-bank, 2008-2011
Revenue of Tech-bank by Product, 2008-2011
Revenue of Tech-bank by Region, 2008-2011
Gross Margin of Major Products of Tech-bank, 2008-2011
R&D Costs and % of Total Revenue of Tech-bank, 2008-2011
Tech-bank's Sales from Top 5 Clients and % of Total Revenue, 2008-2011
Tech-bank's Procurement from Top 5 Suppliers and % of Total Procurement,
2008-2012
Revenue and Gross Margin of Tech-bank's Biological Products Business,
2008-2012
Revenue and Net Income of Tech-bank, 2011-2013E
Revenue and Net Income of Shenghua Biok, 2008-2011
Revenue of Shenghua Biok by Product, 2008-2011
Revenue of Shenghua Biok by Region, 2008-2011
Gross Margin of Main Products of Shenghua Biok, 2008-2011
Shenghua Biok's Sales from Top 5 Clients and % of Total Revenue, 2008-2011
Shenghua Biok's Procurement from Top 5 Suppliers and % of Total
Procurement, 2008-2012
Revenue and Net Income of Qingdao Yebio, 2008-2011
Revenue and Net Income of Shenghua Biok, 2011-2013E
Revenue and Net Income of Huasun Group, 2008-2011
Revenue of Huasun Group by Product, 2008-2011
Revenue of Huasun Group by Region, 2008-2011
Gross Margin of Main Products of Huasun Group, 2008-2011
Huasun Group's Sales from Top 5 Clients and % of Total Revenue, 2008-2011
Huasun Group's Procurement from Top 5 Suppliers and % of Total
Procurement, 2008-2011
Revenue of Huasun Animal Bioproducts Co., Ltd., 2008-2011
Revenue and Net Income of Huasun Group, 2011-2013E
Revenue and Net Income of Ringpu, 2008-2011
Revenue of Ringpu by Product, 2008-2011
Revenue of Ringpu by Region, 2008-2011
Gross Margin of Main Products of Ringpu, 2008-2011
R&D Costs and % of Total Revenue of Ringpu, 2008-2012
Ringpu's Sales from Top 5 Clients and % of Total Revenue, 2008-2012
Ringpu's Procurement from Top 5 Suppliers and % of Total Procurement,
2008-2012
Ringpu's Animal Vaccine Subsidiaries and Their Net Income, 2011
Production of Newly-added Capacity of Ringpu, 2012
Sales of Market-oriented Vaccines and Its Proportion in Ringpu's Revenue,
2009-2011
Revenue and Net Income of Ringpu, 2011-2013E
Revenue and Net Income of Dahuanong, 2008-2011
Revenue of Dahuanong by Product, 2008-2011
Revenue of Dahuanong by Region, 2008-2011
Gross Margin of Major Products of Dahuanong, 2008-2011
R&D Costs and % of Total Revenue of Dahuanong, 2008-2011
Dahuanong's Sales from Top 5 Clients and % of Total Revenue, 2008-2011
Revenue and Gross Margin of Dahuanong's Animal Vaccine Business, 2008-2011
Revenue and Net Income of Dahuanong, 2011-2013E
Revenue and Net Income of Yikang, 2009-2011
Revenue of Yikang by Product, 2009-2011
Revenue of Yikang by Region, 2009-2011
Gross Margin of Main Products of Yikang, 2009-2011
R&D Costs and % of Total Revenue of Yikang, 2009-2012
Yikang's Sales from Top 5 Clients and % of Total Revenue, 2009-2011
Name list and Revenue Contribution of Yikang's Top 5 Clients, 2011
Yikang's Procurement from Top 5 Suppliers and % of Total Procurement,
2009-2011
Name list, procurement and % of Yikang's Top 5 Suppliers, 2011
Animal Vaccine Production Lines of Yikang, 2009-2011
Capacity, Output and Capacity Utilization of Yikang, 2009-2011
Output, Sales Volume and Sales-output Ratio of Yikang, 2009-2011
Average Sale Prices of Yikang's Major Products, 2009-2011
Revenue of Yikang by Sales Model, 2009-2011
Revenue and Net Income of Chopper, 2009-2011
Revenue of Chopper by Product, 2009-2011
Revenue of Chopper by Region, 2009-2011
Gross Margin of Main Products of Chopper, 2009-2011
R&D Costs and % of Total Revenue of Chopper, 2009-2011
Chopper's Sales from Top 5 Clients and % of Total Revenue, 2009-2011
Name list and Revenue Contribution of Chopper's Top 5 Clients, 2011
Sales Contracts of Chopper and Animal Husbandry and Veterinary Bureau of
Hubei Province, 2011
Chopper's Procurement from Top 5 Suppliers and % of Total
Procurement,2009-2011
Name list, procurement and % of Chopper's Top 5 Suppliers, 2011
Capacity, Output and Capacity Utilization of Chopper, 2009-2011
Output, Sales Volume and Sales-output Ratio of Chopper, 2009-2011
Average Sale Prices of Chopper's Major Products, 2009-2011
Investment Plan of Chopper, 2012
China Animal Vaccine Industry Report, 2011-2012 published by ResearchInChina in June 1, 2012. This report consists of 117 Pages and the price starts from US $ 2400.
The contents of this page may be different from the latest version. Please contact us for details.
